Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, how much the NHS has spent on statins in each year since 2010.
The information requested is provided. The fall in costs over the period is largely due to patent expiry and the entry of cheaper generic medicines.
Net ingredient cost (NIC) for statin prescription items written in the United Kingdom and dispensed in the community in England, 2010 to 2015, as defined by British National Formulary (BNF) section 2.12 Lipid regulating drugs 1, 2, 3 | |
Year | NIC (£000’s) |
2010 | 452,888.8 |
2011 | 439,941.9 |
2012 | 288,875.5 |
2013 | 153.873.6 |
2014 | 148,976.4 |
2015 | 155,450.5 |
Source: Prescription Cost Analysis system data provided by NHS Digital
Notes:
1 NIC is the basic cost of a drug. It does not take account of discounts, dispensing costs, fees or prescription charges income.
2 Based on the BNF classification system prior to edition 70.
3 All statins within BNF section 2.12 have been extracted: Atorvastatin, Cerivastatin, Fluvastatin Sodium, Pravastatin Sodium, Rosuvastatin Calcium, Simvastatin, Simvastatin and Ezetimibe.